Bioventus BVS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $51.24M+23.2% | $41.58M+12.5% | $36.96M+16.1% | $31.84M-67.9% | ||
| $520.65M-0.6% | $523.87M+5.3% | $497.67M-10.0% | $553.2M+27.1% | ||
| $369.02M+0.5% | $367.12M-3.8% | $381.74M+26.8% | $301.16M+69.5% | ||
| $21.24M-3.9% | $22.1M+4.9% | $21.06M+10.1% | $19.13M+56.7% | ||
| $61M-13.3% | $70.38M+0.2% | $70.27M+4.1% | $67.48M+32.8% | ||
| $11.07M-21.9% | $14.16M-16.3% | $16.91M-8.8% | $18.55M-31.9% | ||
| $272.84M-1.0% | $275.61M+2.8% | $268M-1.7% | $272.58M+3.6% | ||
| $21.9M-18.9% | $27.01M-26.2% | $36.61M+33.3% | $27.46M+19.5% | ||
| 5.2%-650,599,995% | 650,600,000%-684,700,000% | 1,335,300,000%-333,700,000% | 1,669,000,000%-49,600,000% | ||
| $7.46M0.0% | $7.46M0.0% | $7.46M0.0% | $7.46M-94.9% | ||
| $368.42M-9.0% | $404.73M-16.1% | $482.35M-24.6% | $639.85M-8.0% | ||
| $2.29M+21.2% | $1.89M-39.8% | $3.14M+19.8% | $2.62M-91.1% | ||
| $683.56M-6.1% | $727.96M-10.2% | $810.91M-40.9% | $1.37B+12.0% | ||
| $10.93M-53.9% | $23.69M+2.8% | $23.04M-37.2% | $36.7M+117% | ||
| $4.21M+7.5% | $3.92M-18.7% | $4.82M+33.5% | $3.61M+1.4% | ||
| $15M-45.1% | $27.34M-1.8% | $27.85M-15.8% | $33.06M+83.3% | ||
| $3.3M+6.5% | $3.1M-23.5% | $4.06M+14.2% | $3.55M+1.4% | ||
| $907K+11.3% | $815K+7.4% | $759K+1,280% | $55K— | ||
| $5.14M+32.8% | $3.87M-18.6% | $4.75M+84.6% | $2.57M-68.4% | ||
| $3.17M-40.5% | $5.32M-19.4% | $6.61M+2,944% | $217K— | ||
| $160.38M-23.8% | $210.4M+19.9% | $175.5M-42.3% | $304.02M+68.1% | ||
| $278.95M-9.5% | $308.29M-16.0% | $367M-4.7% | $385.01M+13.4% | ||
| $4.46M-35.8% | $6.94M-34.4% | $10.57M-26.3% | $14.36M-4.5% | ||
| $9.64M-7.2% | $10.39M-6.8% | $11.15M+8,408% | $131K— | ||
| $7.76M-22.7% | $10.04M-31.4% | $14.63M-18.3% | $17.91M-3.4% | ||
| $8.73M-8.8% | $9.57M-7.8% | $10.39M+13,566% | $76K— | ||
| $15.35M-33.6% | $23.1M-17.3% | $27.93M+22.5% | $22.81M+5.0% | ||
| $455.11M-16.1% | $542.35M-8.0% | $589.79M-38.6% | $960.43M+55.4% | ||
| $520.85M+2.5% | $508.09M+2.8% | $494.25M+0.7% | $490.58M+3.6% | ||
| -$334.93M+6.4% | -$357.66M-11.2% | -$321.54M-94.5% | -$165.31M-2,404% | ||
| -$1.9M+26.2% | -$2.57M-424% | $794K+822% | -$110K-161% | ||
| $44.34M+17.7% | $37.66M-20.8% | $47.53M-45.4% | $86.98M-38.2% | ||
| $184.11M+24.4% | $147.94M-14.8% | $173.59M-46.6% | $325.24M-29.1% | ||
| $683.56M-6.1% | $727.96M-10.2% | $810.91M-40.9% | $1.37B+12.0% | ||
| $2.9M+1.4% | $2.86M-32.1% | $4.22M-39.9% | $7.02M+106% | ||
| $2.9M+1.4% | $2.86M-32.1% | $4.22M-39.9% | $7.02M+106% | ||
| $21.24M-3.9% | $22.1M+4.9% | $21.06M+10.1% | $19.13M+56.7% | ||
| $5.12M-21.3% | $6.51M-51.3% | $13.35M-20.0% | $16.69M-2.9% | ||
| $5.52M+16.4% | $4.75M— | $0— | $0-100% | ||
| $5.52M+16.4% | $4.75M— | $0— | —— | ||
| $368.42M-9.0% | $404.73M-16.1% | $482.35M-24.6% | $639.85M-8.0% | ||
| $2.29M+21.2% | $1.89M-39.8% | $3.14M+19.8% | $2.62M-91.1% | ||
| $5.12M-21.3% | $6.51M-51.3% | $13.35M-20.0% | $16.69M-2.9% | ||
| $21.9M-18.9% | $27.01M-26.2% | $36.61M+33.3% | $27.46M+19.5% | ||
| $5.12M-21.3% | $6.51M-51.3% | $13.35M-20.0% | $16.69M-2.9% | ||
| $130.24M-4.1% | $135.88M+13.4% | $119.8M+7.4% | $111.57M-15.1% | ||
| $130.24M-4.1% | $135.88M+13.4% | $119.8M+7.4% | $111.57M-15.1% | ||
| $4.21M+7.5% | $3.92M-18.7% | $4.82M+33.5% | $3.61M+1.4% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $570K-50.3% | $1.15M+25.1% | $917K-31.5% | $1.34M-20.7% | ||
| $311.35M-12.6% | $356.06M-15.4% | $420.62M-3.6% | $436.1M+15.9% | ||
| $7.78M-54.4% | $17.05M— | —— | —— | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| —— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 4.7M+0.8% | 4.6M+6.5% | 4.3M-51.2% | 8.9M+6.5% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $7.77+0.5% | $7.73-10.9% | $8.68-25.5% | $11.65+4.4% | ||
| —— | —— | —— | —— | ||
| $25.04M-23.3% | $32.65M+68.0% | $19.44M+112% | $9.18M-60.7% | ||
| $6.56M-13.7% | $7.6M-21.7% | $9.71M-15.0% | $11.43M+7.2% | ||
| $2.9M+1.4% | $2.86M-32.1% | $4.22M-39.9% | $7.02M+106% | ||
| $1.73M+58.6% | $1.09M-35.3% | $1.69M+28.8% | $1.31M-5.3% | ||
| $433K-23.2% | $564K-53.5% | $1.21M-46.0% | $2.25M-96.2% | ||
| —— | —— | —— | —— | ||
| $907K+11.3% | $815K+7.4% | $759K+1,280% | $55K— | ||
| $11.22M-11.7% | $12.7M-11.0% | $14.28M+11,055% | $128K— | ||
| $73.49M+10.7% | $66.41M+11.4% | $59.59M-16.3% | $71.23M+4.8% | ||
| 30.0% | 30.0% | 3— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $44.34M+17.7% | $37.66M-20.8% | $47.53M-45.4% | $86.98M-38.2% | ||
| $0.05+2.0% | $0.05+8.5% | $0.05-2.1% | $0.05+2.1% | ||
| $16.85M-15.9% | $20.04M+1.7% | $19.7M+16.3% | $16.95M-20.7% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $4.66M+0.8% | $4.63M+6.5% | $4.35M-51.2% | $8.91M+6.5% | ||
| $7.77+0.5% | $7.73-10.9% | $8.68-25.5% | $11.65+4.4% | ||
| —— | —— | —— | —— | ||
| $7.78M-54.4% | $17.05M— | —— | —— | ||
| —— | —— | —— | —— | ||
| 8.1%0.0% | 8.1%0.0% | 8.1%+4.8% | 3.3%— | ||
| $0.080.0% | $0.080.0% | $0.08+145% | $0.03— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bioventus's total assets?
- Bioventus (BVS) holds $650.5M in total assets, down 5.9% year over year.
- How much debt does Bioventus have?
- Bioventus carries $288.4M in total debt against $188.9M of shareholders' equity, a debt-to-equity ratio of 1.53.
- How much cash does Bioventus have?
- Bioventus holds $35.8M in cash and equivalents.
- Can Bioventus cover its short-term obligations?
- Its current ratio is 1.69 — current assets exceed current liabilities.
- Where does Bioventus's balance sheet data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
